Capricor Therapeutics Inc (CAPR)
$6.38 -3.77% Close Oct 30, 2026 Live
Capricor Therapeutics stock today
Capricor Therapeutics closed at $6.38 on October 30, 2026, down 3.77% on the day. Over the past year it returned +2.7% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $369 million.
$10.00$20.00$30.00
NovJan 2026MarMayJulSep
| Period | CAPR | S&P 500 (SPY) |
|---|---|---|
| 1 month | -32.6% | -0.9% |
| 3 months | +52.3% | +2.1% |
| Year to date | -77.9% | +11.7% |
| 1 year | +2.7% | +12.4% |
| 3 years | +130.3% | +88.5% |
| 5 years | +71.5% | +76.0% |
Key statistics
- Market value
- $369M
- 52-week range
- $3.85 to $35.34
- Next report
- Nov 10, 2026
About Capricor Therapeutics
Biopharmaceutical company developing therapies for cardiovascular and infectious diseases.
Sector: Health Care
More on Capricor Therapeutics
- Financials: revenue, earnings and segmentsRevenue -12% in the year to Dec 2024
- Returns: what $1,000 became$1,000 ten years ago is $196.31 today
No forecast, no recommendation. This page describes Capricor Therapeutics Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.